CG Oncology (CGON) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist

24.640
-0.450-1.79%

Close Feb 27 16:00 ET

24.750
+0.110+0.45%

Post 17:25 ET

1.85BMarket Cap-21.13P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
GlobeNewswireFeb 26 08:00 ET
Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now
Yahoo FinanceFeb 20 12:19 ET
BofA Securities Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $65
Moomoo NewsFeb 13 07:33 ET · Ratings
CG Oncology, Inc. (NASDAQ:CGON) Is a Favorite Amongst Institutional Investors Who Own 62%
Yahoo FinanceFeb 3 07:05 ET
Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect?
Yahoo FinanceJan 16 09:55 ET
CG Oncology Amends Key Executive Employment Agreements
TipRanksJan 10 16:49 ET

Comments

Teo knows

Nov 25, 2024 08:57

$CG Oncology (CGON.US)$ fly

Meltyy

May 22, 2024 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Meltyy

Apr 18, 2024 03:34

🎯 Ph 3 readouts in Q2 2024...

$Travere Therapeutic (TVTX.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phas...

Meltyy

Apr 1, 2024 02:47

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3...

Moomoo AI

Jan 26, 2024 10:59

CG Oncology's successful IPO hints at a possible resurgence of investor interest in biotech stocks, despite the sector's recent underperformance. This strong debut is viewed as a positive indicator for the sector's future.

Biotech's First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks. -- Barrons.com

CGON CG Oncology

Trade Overview

Capital Trend

News

Comments

Trending Stocks